| |
Latest 10 SEC filings (by transaction date) for SRPT within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 11/24 | Mar 11/24 | Boor Kathryn Jean | Direct Ownership | Common Stock | S - Open market or private sale | -761 | $122.93 |
Mar 11/24 | Mar 8/24 | Wigzell Hans Lennart Rudolf | Direct Ownership | Stock Option (right to buy) | M - Exercise or conversion exempt under rule 16b-3 | -15,000 | |
Mar 11/24 | Mar 8/24 | Wigzell Hans Lennart Rudolf | Direct Ownership | Common Stock | S - Open market or private sale | -100 | $122.39 |
Mar 11/24 | Mar 8/24 | Wigzell Hans Lennart Rudolf | Direct Ownership | Common Stock | S - Open market or private sale | -11,745 | $123.10 |
Mar 11/24 | Mar 8/24 | Wigzell Hans Lennart Rudolf | Direct Ownership | Common Stock | S - Open market or private sale | -3,155 | $123.85 |
Mar 11/24 | Mar 8/24 | Wigzell Hans Lennart Rudolf | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 15,000 | $13.90 |
Mar 11/24 | Mar 8/24 | Arif Bilal | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -472 | $123.14 |
Mar 11/24 | Mar 8/24 | Rodino-Klapac Louise | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -909 | $123.14 |
Mar 11/24 | Mar 8/24 | Brown Ryan Edward | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -899 | $123.14 |
Mar 11/24 | Mar 8/24 | Estepan Ian Michael | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -1,035 | $123.14 |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for SRPT within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 11/24 | Mar 8/24 | Wigzell Hans Lennart Rudolf | Direct Ownership | Stock Option (right to buy) | M - Exercise or conversion exempt under rule 16b-3 | -15,000 | |
Mar 11/24 | Mar 8/24 | Wigzell Hans Lennart Rudolf | Direct Ownership | Common Stock | S - Open market or private sale | -100 | $122.39 |
Mar 11/24 | Mar 8/24 | Wigzell Hans Lennart Rudolf | Direct Ownership | Common Stock | S - Open market or private sale | -11,745 | $123.10 |
Mar 11/24 | Mar 8/24 | Wigzell Hans Lennart Rudolf | Direct Ownership | Common Stock | S - Open market or private sale | -3,155 | $123.85 |
Mar 11/24 | Mar 8/24 | Wigzell Hans Lennart Rudolf | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 15,000 | $13.90 |
Mar 11/24 | Mar 8/24 | Arif Bilal | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -472 | $123.14 |
Mar 11/24 | Mar 7/24 | Arif Bilal | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -506 | $120.49 |
Mar 11/24 | Mar 8/24 | Rodino-Klapac Louise | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -909 | $123.14 |
Mar 11/24 | Mar 7/24 | Rodino-Klapac Louise | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -512 | $120.49 |
Mar 11/24 | Mar 11/24 | Boor Kathryn Jean | Direct Ownership | Common Stock | S - Open market or private sale | -761 | $122.93 |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Neurocrine Biosciences (OQ:NBIX) |
Regeneron Pharmaceuticals (OQ:REGN) |
Madrigal Pharmaceuticals (OQ:MDGL) |